Literature DB >> 2803927

Heterogeneous response to differentiation induction with different polar compounds in a clonal rat rhabdomyosarcoma cell line (BA-HAN-1C).

C D Gerharz1, H E Gabbert, R Engers, U Ramp, H Mayer, C Luley.   

Abstract

The clonal rat rhabdomyosarcoma cell line BA-HAN-1C was tested for its susceptibility to differentiation induction with different polar compounds. This cell line is composed of proliferating mononuclear tumour cells, some of which spontaneously fuse to form terminally differentiated postmitotic myotube-like giant cells. Exposure of BA-HAN-1C cells to dimethylsulphoxide (DMSO), hexamethylene bisacetamide (HMBA), sodium butyrate (NaBut) and N-monomethylformamide (NMF) resulted in a significant inhibition of proliferation (P less than 0.001) and in a simultaneous increase in differentiation. The response was most pronounced after exposure to NMF as evidenced by a marked increase in the creatine kinase activity used as a biochemical marker of differentiation (P less than 0.05) and the number of terminally differentiated myotube-like giant cells (P less than 0.001). Furthermore, about 5% of the mononuclear cells exhibited thick and thin myofilaments which were never observed in the mononuclear cells of the control. In contrast, the effects of DMSO, HMBA and NaBut were exclusively confined to a significant increase in biochemical differentiation (P less than 0.05), whereas no increase in morphological differentiation was observed and the number of myotube-like giant cells even significantly (P less than 0.001) decreased. This heterogeneous response to differentiation induction with different polar compounds probably indicates different mechanisms of action and suggests that the induction of biochemical differentiation might be independently regulated from events leading to cell fusion and terminal differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2803927      PMCID: PMC2247115          DOI: 10.1038/bjc.1989.317

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Induction of differentiation of HL-60 cells by dimethyl sulfoxide: evidence for a stochastic model not linked to the cell division cycle.

Authors:  C Tarella; D Ferrero; E Gallo; G L Pagliardi; F W Ruscetti
Journal:  Cancer Res       Date:  1982-02       Impact factor: 12.701

2.  Expression of myogenic differentiation and myotube formation by chick embryo myoblasts in the presence of sodium butyrate.

Authors:  M Y Fiszman; D Montarras; W Wright; F Gros
Journal:  Exp Cell Res       Date:  1980-03       Impact factor: 3.905

3.  N,N-dimethylformamide and sodium butyrate modulation of the activities of purine-metabolizing enzymes in cultured human colon carcinoma cells.

Authors:  D L Dexter; G W Crabtree; J D Stoeckler; T M Savarese; L Y Ghoda; T L Rogler-Brown; R E Parks; P Calabresi
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

Review 4.  Induction of differentiation in neoplastic cells.

Authors:  R I Freshney
Journal:  Anticancer Res       Date:  1985 Jan-Feb       Impact factor: 2.480

5.  Manipulation of myogenesis in vitro: reversible inhibition by DMSO.

Authors:  H M Blau; C J Epstein
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

6.  Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression.

Authors:  T T Amatruda; N Sidell; J Ranyard; H P Koeffler
Journal:  Biochem Biophys Res Commun       Date:  1985-02-15       Impact factor: 3.575

7.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

8.  Polar solvent-induced changes in membrane lipid lateral diffusion in human colon cancer cells.

Authors:  M D Dibner; K A Ireland; L A Koerner; D L Dexter
Journal:  Cancer Res       Date:  1985-10       Impact factor: 12.701

9.  Hypomethylation of DNA during differentiation of Friend erythroleukemia cells.

Authors:  J K Christman; N Weich; B Schoenbrun; N Schneiderman; G Acs
Journal:  J Cell Biol       Date:  1980-08       Impact factor: 10.539

Review 10.  The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.

Authors:  A C Sartorelli
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

View more
  5 in total

1.  In vitro differentiation and proliferation in a newly established human rhabdomyosarcoma cell line.

Authors:  A Ogose; T Motoyama; T Hotta; H Watanabe
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Modulation of invasive potential in different clonal subpopulations of a rat rhabdomyosarcoma cell line (BA-HAN-1) by differentiation induction.

Authors:  C D Gerharz; M E Bracke; M M Mareel; H E Gabbert
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

3.  Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

Authors:  G Nicoletti; C De Giovanni; L Landuzzi; G Simone; P Rocchi; P Nanni; P L Lollini
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

4.  In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.

Authors:  P Nanni; G Azzarello; L Tessarollo; C De Giovanni; P L Lollini; G Nicoletti; K Scotlandi; L Landuzzi; M Panozzo; E D'Andrea
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

5.  Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

Authors:  C De Giovanni; P L Lollini; R Dolcetti; L Landuzzi; G Nicoletti; E D'Andrea; K Scotland; P Nanni
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.